The Epidemiological, Clinical, and Microbiological Features of Patients with Burkholderia pseudomallei Bacteraemia-Implications for Clinical Management
- PMID: 37999600
- PMCID: PMC10675116
- DOI: 10.3390/tropicalmed8110481
The Epidemiological, Clinical, and Microbiological Features of Patients with Burkholderia pseudomallei Bacteraemia-Implications for Clinical Management
Abstract
Patients with melioidosis are commonly bacteraemic. However, the epidemiological characteristics, the microbiological findings, and the clinical associations of Burkholderia pseudomallei bacteraemia are incompletely defined. All cases of culture-confirmed melioidosis at Cairns Hospital in tropical Australia between January 1998 and June 2023 were reviewed. The presence of bacteraemia was determined and correlated with patient characteristics and outcomes; 332/477 (70%) individuals in the cohort were bacteraemic. In multivariable analysis, immunosuppression (odds ratio (OR) (95% confidence interval (CI)): (2.76 (1.21-6.27), p = 0.02), a wet season presentation (2.27 (1.44-3.59), p < 0.0001) and male sex (1.69 (1.08-2.63), p = 0.02), increased the likelihood of bacteraemia. Patients with a skin or soft tissue infection (0.32 (0.19-0.57), p < 0.0001) or without predisposing factors for melioidosis (0.53 (0.30-0.93), p = 0.03) were less likely to be bacteraemic. Bacteraemia was associated with intensive care unit admission (OR (95%CI): 4.27 (2.35-7.76), p < 0.0001), and death (2.12 (1.04-4.33), p = 0.04). The median (interquartile range) time to blood culture positivity was 31 (26-39) hours. Patients with positive blood cultures within 24 h were more likely to die than patients whose blood culture flagged positive after this time (OR (95%CI): 11.05 (3.96-30.83), p < 0.0001). Bacteraemia portends a worse outcome in patients with melioidosis. Its presence or absence might be used to help predict outcomes in cases of melioidosis and to inform optimal clinical management.
Keywords: Australia; Burkholderia pseudomallei; antibiotic therapy; bacteraemia; clinical management; critical care; indigenous health; melioidosis; sepsis; tropical medicine.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures
Similar articles
-
Bone and joint infections due to melioidosis; diagnostic and management strategies to optimise outcomes.PLoS Negl Trop Dis. 2024 Jul 17;18(7):e0012317. doi: 10.1371/journal.pntd.0012317. eCollection 2024 Jul. PLoS Negl Trop Dis. 2024. PMID: 39018296 Free PMC article.
-
The Darwin Prospective Melioidosis Study: a 30-year prospective, observational investigation.Lancet Infect Dis. 2021 Dec;21(12):1737-1746. doi: 10.1016/S1473-3099(21)00022-0. Epub 2021 Jul 22. Lancet Infect Dis. 2021. PMID: 34303419
-
Melioidosis-a disease of socioeconomic disadvantage.PLoS Negl Trop Dis. 2021 Jun 21;15(6):e0009544. doi: 10.1371/journal.pntd.0009544. eCollection 2021 Jun. PLoS Negl Trop Dis. 2021. PMID: 34153059 Free PMC article.
-
Melioidosis: An Australian Perspective.Trop Med Infect Dis. 2018 Mar 1;3(1):27. doi: 10.3390/tropicalmed3010027. Trop Med Infect Dis. 2018. PMID: 30274424 Free PMC article. Review.
-
Cutaneous melioidosis in the tropical top end of Australia: a prospective study and review of the literature.Clin Infect Dis. 2008 Sep 1;47(5):603-9. doi: 10.1086/590931. Clin Infect Dis. 2008. PMID: 18643756 Review.
Cited by
-
The characteristics and clinical course of patients with melioidosis and cancer.PLoS Negl Trop Dis. 2024 Oct 25;18(10):e0012631. doi: 10.1371/journal.pntd.0012631. eCollection 2024 Oct. PLoS Negl Trop Dis. 2024. PMID: 39453944 Free PMC article.
-
Bone and joint infections due to melioidosis; diagnostic and management strategies to optimise outcomes.PLoS Negl Trop Dis. 2024 Jul 17;18(7):e0012317. doi: 10.1371/journal.pntd.0012317. eCollection 2024 Jul. PLoS Negl Trop Dis. 2024. PMID: 39018296 Free PMC article.
-
The Association Between Statin Therapy and the Subsequent Clinical Course of Patients With Melioidosis.J Trop Med. 2025 May 25;2025:8838580. doi: 10.1155/jotm/8838580. eCollection 2025. J Trop Med. 2025. PMID: 40458113 Free PMC article.
-
The Incidence, Aetiology and Clinical Course of Serious Infections Complicating Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drug Therapy in Patients with Rheumatoid Arthritis in Tropical Australia.Pathogens. 2024 Oct 29;13(11):943. doi: 10.3390/pathogens13110943. Pathogens. 2024. PMID: 39599496 Free PMC article.
References
-
- Fairhead L.J., Smith S., Sim B.Z., Stewart A.G.A., Stewart J.D., Binotto E., Law M., Hanson J. The seasonality of infections in tropical Far North Queensland, Australia: A 21-year retrospective evaluation of the seasonal patterns of six endemic pathogens. PLoS Glob. Public Health. 2022;2:e0000506. doi: 10.1371/journal.pgph.0000506. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources